132 related articles for article (PubMed ID: 37897235)
1. Clinical and immunological characteristics of children diagnosed with-Type 1 diabetes during the COVID-19 pandemic.
Margolis MG; Weizman S; Lazar L; Yakobovich-Gavan M; Tenenbaum A; Phillip M; Oron T
Diabet Med; 2024 May; 41(5):e15250. PubMed ID: 37897235
[TBL] [Abstract][Full Text] [Related]
2. A Long-Term Comparison of Presenting Characteristics of Children with Newly Diagnosed Type 1 Diabetes Before and During the COVID-19 Pandemic.
Kaya G; Cimbek EA; Yeşilbaş O; Bostan YE; Karagüzel G
J Clin Res Pediatr Endocrinol; 2022 Aug; 14(3):267-274. PubMed ID: 35308015
[TBL] [Abstract][Full Text] [Related]
3. Increased frequency of severe diabetic ketoacidosis at type 1 diabetes onset among children during COVID-19 pandemic lockdown: an observational cohort study.
Dżygało K; Nowaczyk J; Szwilling A; Kowalska A
Pediatr Endocrinol Diabetes Metab; 2020; 26(4):167-175. PubMed ID: 33554490
[TBL] [Abstract][Full Text] [Related]
4. The SARS-CoV-2 pandemic is associated with increased severity of presentation of childhood onset type 1 diabetes mellitus: A multi-centre study of the first COVID-19 wave.
McGlacken-Byrne SM; Drew SEV; Turner K; Peters C; Amin R
Diabet Med; 2021 Sep; 38(9):e14640. PubMed ID: 34245598
[TBL] [Abstract][Full Text] [Related]
5. DKA and new-onset type 1 diabetes in Brazilian children and adolescents during the COVID-19 pandemic.
Luciano TM; Halah MP; Sarti MTA; Floriano VG; da Fonseca BAL; Del Roio Liberatore R; Antonini SR
Arch Endocrinol Metab; 2022 Mar; 66(1):88-91. PubMed ID: 35029857
[TBL] [Abstract][Full Text] [Related]
6. New-onset type 1 diabetes in Finnish children during the COVID-19 pandemic.
Salmi H; Heinonen S; Hästbacka J; Lääperi M; Rautiainen P; Miettinen PJ; Vapalahti O; Hepojoki J; Knip M
Arch Dis Child; 2022 Feb; 107(2):180-185. PubMed ID: 34045208
[TBL] [Abstract][Full Text] [Related]
7. Higher rates of diabetic ketoacidosis and admission to the paediatric intensive care unit among newly diagnosed children with type 1 diabetes in Kuwait during the COVID-19 pandemic.
Al-Abdulrazzaq D; Alkandari A; Alhusaini F; Alenazi N; Gujral UP; Narayan KMV; Al-Kandari H;
Diabetes Metab Res Rev; 2022 Mar; 38(3):e3506. PubMed ID: 34679258
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and factors associated with thyroid autoimmunity among children newly diagnosed with type 1 diabetes before and during the COVID-19 pandemic: Evidence from Kuwait.
Al-Abdulrazzaq D; Albatineh AN; Khalifa D; Alrefae A; Al-Awadhi E; Alkandari A; Alhomaidah D; Cunningham SA; Al-Kandari H
Diabetes Metab Res Rev; 2024 Jul; 40(5):e3824. PubMed ID: 38837532
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Positive Serology and Islet Autoantibodies in Newly Diagnosed Pediatric Cases of Type 1 Diabetes Mellitus: A Single-Center Cohort Study.
Boboc AA; Novac CN; Marin AG; Ieșanu MI; Plătică C; Buzescu T; Coșoreanu MT; Galoș F
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240231
[TBL] [Abstract][Full Text] [Related]
10. The global impact of COVID-19 pandemic on the incidence of pediatric new-onset type 1 diabetes and ketoacidosis: A systematic review and meta-analysis.
Rahmati M; Keshvari M; Mirnasuri S; Yon DK; Lee SW; Il Shin J; Smith L
J Med Virol; 2022 Nov; 94(11):5112-5127. PubMed ID: 35831242
[TBL] [Abstract][Full Text] [Related]
11. No effects of COVID-19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of SARS-CoV-2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects.
Tiberti C; Nenna R; Tromba V; Filardi T; Petrarca L; Silvestri F; Fassino V; Montuori M; Mancino E; Lenzi A; Midulla F; Costantino F; Morano S
Acta Diabetol; 2023 Oct; 60(10):1301-1307. PubMed ID: 37171699
[TBL] [Abstract][Full Text] [Related]
12. Changes in the presentation of newly diagnosed type 1 diabetes in children during the COVID-19 pandemic in a tertiary center in Southern Turkey.
Dilek SÖ; Gürbüz F; Turan İ; Celiloğlu C; Yüksel B
J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1303-1309. PubMed ID: 34291625
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Initial Presentation of Pediatric Diabetes Before and During the Coronavirus Disease 2019 Pandemic Era.
Lee Y; Kim M; Oh K; Kang E; Rhie YJ; Lee J; Hong YH; Shin YL; Kim JH
J Korean Med Sci; 2022 Jun; 37(22):e176. PubMed ID: 35668686
[TBL] [Abstract][Full Text] [Related]
14. Increase in the Diagnosis and Severity of Presentation of Pediatric Type 1 and Type 2 Diabetes during the COVID-19 Pandemic.
Marks BE; Khilnani A; Meyers A; Flokas ME; Gai J; Monaghan M; Streisand R; Estrada E
Horm Res Paediatr; 2021; 94(7-8):275-284. PubMed ID: 34564073
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 and type 1 diabetes in children in Finland: an observational study.
Knip M; Parviainen A; Turtinen M; But A; Härkönen T; Hepojoki J; Sironen T; Iheozor-Ejiofor R; Uğurlu H; Saksela K; Lempainen J; Ilonen J; Vapalahti O;
Lancet Diabetes Endocrinol; 2023 Apr; 11(4):251-260. PubMed ID: 36958868
[TBL] [Abstract][Full Text] [Related]
16. Effect of COVID-19 pandemic on presentation and referral patterns of newly diagnosed children with type 1 diabetes in a developing country.
Alassaf A; Gharaibeh L; Ibrahim S; Daher A; Irsheid A; Albaramki J; Odeh R
J Pediatr Endocrinol Metab; 2022 Jul; 35(7):859-866. PubMed ID: 35607289
[TBL] [Abstract][Full Text] [Related]
17. Diabetic ketoacidosis at type 1 diabetes diagnosis in children during the COVID-19 pandemic.
Ho J; Rosolowsky E; Pacaud D; Huang C; Lemay JA; Brockman N; Rath M; Doulla M
Pediatr Diabetes; 2021 Jun; 22(4):552-557. PubMed ID: 33745226
[TBL] [Abstract][Full Text] [Related]
18. The Impact of COVID-19 Pandemic on Prevalence of Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes: A Single-Centre Study in Central Pennsylvania.
Bogale KT; Urban V; Schaefer E; Bangalore Krishna K
Endocrinol Diabetes Metab; 2021 Jul; 4(3):e00235. PubMed ID: 34268453
[TBL] [Abstract][Full Text] [Related]
19. Diabetic ketoacidosis incidence among children with new-onset type 1 diabetes in Poland and its association with COVID-19 outbreak-Two-year cross-sectional national observation by PolPeDiab Study Group.
Pietrzak I; Michalak A; Seget S; Bednarska M; Beń-Skowronek I; Bossowski A; Chobot A; Dżygało K; Głowińska-Olszewska B; Górnicka M; Horodnicka-Józwa A; Jakubek-Kipa K; Jarosz-Chobot P; Marcinkiewicz K; Mazur A; Myśliwiec M; Nazim J; Niechciał E; Noczyńska A; Rusak E; Seifert M; Skotarczyk-Kowalska E; Skowronek A; Szypowska A; Wais P; Walczak M; Wołoszyn-Durkiewicz A; Wysocka-Mincewicz M; Zubkiewicz-Kucharska A; Szadkowska A
Pediatr Diabetes; 2022 Nov; 23(7):944-955. PubMed ID: 35700323
[TBL] [Abstract][Full Text] [Related]
20. Epidemiologic Characteristics of Children with Diabetic Ketoacidosis Treated in a Pediatric Intensive Care Unit in a 10-Year-Period: Single Centre Experience in Croatia.
Lah Tomulić K; Matko L; Verbić A; Milardović A; Severinski S; Kolić I; Baraba Dekanić K; Šerifi S; Butorac Ahel I
Medicina (Kaunas); 2022 May; 58(5):. PubMed ID: 35630055
[No Abstract] [Full Text] [Related]
[Next] [New Search]
